FDA Greenlights New Myasthenia Gravis Drug
(MedPage Today) -- The FDA approved rozanolixizumab-noli (Rystiggo), a neonatal Fc receptor blocker, to treat adults with generalized myasthenia gravis (gMG), UCB announced Tuesday.
The drug is the first approved to treat both of the two most... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 27, 2023 Category: American Health Source Type: news
New AAP Framework for Spotting Problems in Premature Babies New AAP Framework for Spotting Problems in Premature Babies
The guidance from the American Academy of Pediatrics spotlights conditions that premature babies are at risk for developing, as well as what to watch for as children grow older.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 27, 2023 Category: Intensive Care Tags: Pediatrics News Source Type: news
OCD Linked to Adverse Pregnancy and Neonatal Outcomes OCD Linked to Adverse Pregnancy and Neonatal Outcomes
Women with OCD and their children are more likely to have complications during pregnancy and delivery, a new study finds.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - June 26, 2023 Category: Primary Care Tags: Ob/Gyn & Women ' s Health News Source Type: news
Anxiety and depression among perinatal women during the long-term normal prevention of COVID-19 pandemic period in China: a cross-sectional study - Chen W, Peng W, Zhang Y, Zhou H, Zhang M.
BACKGROUND: COVID-19 has increased the probability of occurrence of maternal anxiety and depression in pregnant women. However, there is limited research on anxiety and depression among pregnant women during the long-term normal prevention of COVID-19 pand... (Source: SafetyLit)
Source: SafetyLit - June 24, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Inked with knowledge: Cochrane logo tattoo reflects dedication to evidence-based healthcare
Jheng-Yan Wu shares how Cochrane has impacted his professional development and his clinical practice. A dietitian from Taiwan, Jheng-Yan Wu, has made waves in the global medical community by proudly displaying a permanent Cochrane logo tattoo on his forearm. Wu ' s decision to immortalize the iconic symbol in a tattoo signifies his unwavering dedication to evidence-based healthcare and the application of systematic reviews and meta-analysis in his clinical practice.Wu ' s journey with Cochrane began in 2018 when he was first introduced to evidence-based medicine. Captivated by Cochrane ' s emphasis on global collaboratio...
Source: Cochrane News and Events - June 19, 2023 Category: Information Technology Authors: Muriah Umoquit Source Type: news
